Lowering insulin stops new skin tags and treats the real risk — but existing ones won’t fall off on their own. Here’s what actually works, and why.
Do Skin Tags Go Away If You Fix Your Insulin? Read More »
If your boils keep coming back after antibiotics, they may not be an infection. Here’s the link between hidradenitis suppurativa and insulin resistance.
Why Do My Boils Keep Coming Back After Antibiotics? Read More »
That dark, velvety patch on your neck usually isn’t dirt — it’s one of the most specific skin signs of high insulin. Here’s what it means and what to do.
Why Is the Skin on My Neck Getting Dark? (It May Be Your Insulin) Read More »
Ozempic doesn’t cause blindness — but a 2026 JAMA study found a real signal for NAION, an optic nerve stroke. Here’s who it applies to, and who it doesn’t.
Does Ozempic Cause Blindness? What the 2026 Data Actually Shows Read More »
In the head-to-head ACHIEVE-3 trial, oral orforglipron (Foundayo) beat the oral semaglutide pill on blood sugar and weight loss in type 2 diabetes — but with more GI side effects, double the dropout rate, and no cardiovascular indication yet. Here’s what that tradeoff actually means.
Orforglipron vs Oral Semaglutide Pill: What the ACHIEVE-3 Trial Actually Showed Read More »
The first GLP-1 pill (orforglipron/Foundayo) is FDA approved and now cheaper. A metabolic nurse practitioner compares the pill to Wegovy and Zepbound with sourced trial data.
GLP-1 Pill vs Injection: Is Orforglipron as Good as the Shot? (2026) Read More »
Stopping Ozempic or Zepbound brings back most — not all — of the weight. A nurse practitioner reads the 2026 trial data and the new 5 mg maintenance option.
What Happens to Your Weight When You Stop Taking a GLP-1? Read More »
Three new studies link GLP-1 medications to lower breast cancer rates. A DNP explains what the data actually shows, the comparison that breaks the headline, and the metabolic lever you control.
Does GLP-1 Lower Breast Cancer Risk? What Three New Studies Actually Show Read More »
The Natasha doll is a viral squishy stress toy shaped like a caricatured Black baby, and reporting describes a trend of people abusing the dark-skinned version for “stress relief.” Beyond how offensive that is, it points to something measurable: the physical toll that chronic racial stress takes on the body, known as allostatic load. Here
The Natasha Doll, Explained: What the Viral Trend Reveals About Stress and Your Body Read More »
Yes — skin tags are a documented marker of insulin resistance. Here is the mechanism, what it does and does not tell you, and where GLP-1 medications fit in.
Do Skin Tags Mean Insulin Resistance? What Your Skin Is Telling You Read More »
